Has Singapore's invention of '' to derive human stem cells
from an embryo''was stolen by US scientist,who patented it
and
Sg had to pay for it for years!!?
The US scientist had visited NUS.
James A.
Thomson
[email protected]
Dr Ariff
Bongso
Read it folks.This little red dot can do somethings.
Read last Saturday 28.04.2007 Strait Times page 58,59
for full story.I know u will tell me dunt believe ST.
Aye Aye sir.Can u pl also surf the net to see
how
Prof Ariff Bongso became the first scientist to derive human
stem cells from an embryo, but he never patented his work. "The
climate in Asia at that time was publish, not patent," he said.
.
WHat a man research for benefits of mankind.
Compare with the US one.....
1.
More Biotechnology news.Embryonic stem cell pioneer chose to
publish, not patent ,By Terri Somers,UNION-TRIBUNE STAFF
WRITER,April 16, 2007
--http://www.signonsandiego.com/news/business/biotech/20070416-9999-1n16bongso.html
(Prof Ariff) Bongso made the connection between his area of
expertise, human embryology, and stem cells, and just went for it,
said Jeanne Loring, a stem cell researcher at the Burnham Institute
for Medical Research in La Jolla. That's how great scientific
discoveries are made, for the sake of curiosity.
But Bongso never patented his work.
For almost a decade, the fame and financial benefit of being the
first to derive human embryonic stem cells has been heaped upon
James Thomson and the University of Wisconsin...
In October 1994, his article was published but it failed to
generate much interest.
Bongso forged ahead, concentrating on growing the stem cells on
fallopian tube cells, which had proved to be the trick with
embryos. His method never allowed the stem cells to grow past two
generations....
Through 1995, 1996 and 1997, no one seemed interested in my work,
Bongso said. A scientist gauges his work based on the interest
that other scientists show in carrying forward his work. When there
was no interest, I lost interest. I moved on.
In 1998, the university(University of Wisconsin) received its first
U.S. patents for Thomson's work growing monkey and human embryonic
stem cells. The university's three patents give it control of all
human embryonic stem cells used in the United States. Anyone in the
nation who wants to conduct research using the cells must receive a
license from the university, which is reported to charge as much as
$250,000.
On April 2, the U.S. Patent and Trademark Office issued a ruling
that may invalidate the Wisconsin patents. Bongso's work was
identified as proof that what Thomson did was not new and unique.
...
http://californiastemcellreport.blogspot.com/
2.April 2, 2007: PTO REJECTS HUMAN
STEM CELL PATENTS AT BEHEST OF CONSUMER GROUPS:
Re-examination Was Initiated by Foundation for Taxpayer and
Consumer Rights and Public Patent Foundation
It is not easy for US Patent office to do this.
3.This can cause defamation case.
"This change in licensing policy ignores the underlying
fact that WARF's patents are wholly without merit because James
Thomson did not -- in fact -- invent human embryonic stem
cells," said Dan Ravicher executive director of the Public Patent
Foundation. "The right thing for WARF to do is admit that it
doesn't deserve the patents and abandon them in their
entirety."
But Patent Office revoked the patent.
FTCR and PUBPAT argued that the work done by University
of Wisconsin researcher James Thomson to isolate stem cell
lines was obvious in the light of previous scientific research,
making his work unpatentable. To receive a patent, something must
be new, useful and non-obvious. The PTO agreed with the groups.
Ariff Bongso became the first scientist to derive human stem cells
from an embryo, but he never patented his work. "The climate in
Asia at that time was publish, not patent," he said.
